Outpatient Epcoritamab in Large B-cell Lymphoma

Clinical trial NCT06811272 · RECRUITING

Trial details

NCT number: NCT06811272
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Large B-cell Lymphoma Refractory Large B-cell Lymphoma

Start date: 2025-06-05
Primary completion: 2026-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.